Regulation of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in thyroid carcinoma cells
about
Phosphatase of regenerating liver-3 promotes motility and metastasis of mouse melanoma cellsAnaplastic thyroid cancer: molecular pathogenesis and emerging therapies.IL-10 reduces levels of apoptosis in Toxoplasma gondii-infected trophoblasts.Anticancer activity of the type I insulin-like growth factor receptor antagonist, ganitumab, in combination with the death receptor 5 agonist, conatumumab.Cellular FLICE-inhibitory protein: an attractive therapeutic target?Tracking death dealing by Fas and TRAIL in lymphatic neoplastic disorders: pathways, targets, and therapeutic tools.Treatment of hematologic malignancies and solid tumors by inhibiting IGF receptor signaling.TRAIL recombinant adenovirus triggers robust apoptosis in multidrug-resistant HL-60/Vinc cells preferentially through death receptor DR5Combined modality therapy with TRAIL or agonistic death receptor antibodies.Differential modulation of the TRAIL receptors and the CD95 receptor in colon carcinoma cell lines.Targeted therapeutic approach for an anaplastic thyroid cancer in vitro and in vivo.Prevention of posterior capsule opacification by the induction of therapeutic apoptosis of residual lens cells.A Novel Role of IGF1 in Apo2L/TRAIL-Mediated Apoptosis of Ewing Tumor Cells.Expression of type 1 insulin-like growth factor receptor in marrow nucleated cells in malignant hematological disorders: correlation with apoptosis.
P2860
Q24672163-892278E2-36E2-4B55-B34C-98C15B90DB2FQ33691759-6F97264B-F751-4C12-BA32-23875E4077DFQ34590090-F4BAB3F4-B471-4467-AD76-AB9795ED7049Q35050195-6A0EF3AD-23EA-45F3-894D-93EAB71CD680Q35186676-4FF6D994-C1E0-461E-81E5-330B1E13579EQ35209364-777A4E1E-FA63-40FA-BEFA-9C95A294707CQ36185627-541E8BD2-0976-4F30-B100-FEE3775478E8Q37322648-BDAF219D-63A9-4876-A152-21C4FE5E822BQ37832083-E64A9317-912F-4537-9E0B-5893ECE3CCF0Q38601765-BDF80F06-B06E-4B2B-B0A3-A66383641103Q39963021-C49BE4B7-BC15-43EA-AD06-72836E3B0E0DQ40357610-436401E5-E082-4232-97D9-FB66611BACFFQ42429522-45741BA7-8217-4288-A3B3-F31F8C6AA572Q53351748-77B008B2-9EF2-4250-9DDC-D207070C47AD
P2860
Regulation of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in thyroid carcinoma cells
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Regulation of Apo2L/tumor necr ...... sis in thyroid carcinoma cells
@en
Regulation of Apo2L/tumor necr ...... sis in thyroid carcinoma cells
@nl
type
label
Regulation of Apo2L/tumor necr ...... sis in thyroid carcinoma cells
@en
Regulation of Apo2L/tumor necr ...... sis in thyroid carcinoma cells
@nl
prefLabel
Regulation of Apo2L/tumor necr ...... sis in thyroid carcinoma cells
@en
Regulation of Apo2L/tumor necr ...... sis in thyroid carcinoma cells
@nl
P2093
P2860
P1476
Regulation of Apo2L/tumor necr ...... sis in thyroid carcinoma cells
@en
P2093
Avi Ashkenazi
Constantine S Mitsiades
Demetrios A Koutras
Nicholas Mitsiades
Sophia Tseleni-Balafouta
Vassiliki Kotoula
Vassiliki Poulaki
P2860
P304
P356
10.1016/S0002-9440(10)64220-4
P407
P577
2002-08-01T00:00:00Z